Xometry stock price target raised to $50 from $45 at Citizens JMP

Published 06/08/2025, 10:06
Xometry stock price target raised to $50 from $45 at Citizens JMP

Investing.com - Citizens JMP has raised its price target on Xometry Inc (NASDAQ:XMTR) to $50.00 from $45.00 while maintaining a Market Outperform rating. The stock has shown remarkable momentum, gaining over 42% in the past week alone, according to InvestingPro data.

The firm cited Xometry’s better-than-expected financial results, with revenue and EBITDA exceeding the high end of guidance by $5.5 million (3.5%) and $1.9 million (approximately double), respectively. The company has maintained strong revenue growth of 19.35% over the last twelve months, though InvestingPro analysis indicates the stock is currently trading above its Fair Value.

Key performance indicators showed positive trends, including the addition of 3,300 new Active Buyers and accelerated growth of 15% year-over-year in the $50,000+ Active Buyer segment, while marketplace revenue decelerated by only 100 basis points despite a nearly two-point tougher comparison. The company maintains a healthy financial position with a current ratio of 3.74, indicating strong liquidity to support its growth initiatives.

Citizens JMP noted that Xometry is gaining market share in custom manufacturing despite ongoing macro headwinds in the manufacturing sector, positioning the company on a path to achieve over $1 billion in revenue while driving 20%+ incremental EBITDA margins.

The firm believes Xometry’s growth has reset to the mid-20% range after teens growth in 2024, supported by greater coverage of Instant Quoting and deeper integrations across manufacturers’ software and processes.

In other recent news, Xometry Inc. reported impressive second-quarter 2025 earnings, significantly surpassing expectations. The company achieved an earnings per share of $0.09, more than double the forecast of $0.0439, representing a surprise of 105.01%. Revenue also exceeded projections, coming in at $163 million compared to the anticipated $156.49 million, marking a 3.87% surprise. Additionally, Xometry experienced a 26% year-over-year growth in marketplace revenue, outpacing management’s guidance of 20-22%. This growth was observed across U.S. enterprises, international markets, and various verticals. In response to these strong results, JPMorgan raised its price target for Xometry to $55 from $38, maintaining an Overweight rating. These developments highlight the company’s robust performance and positive outlook as assessed by analysts.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.